Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
04/2013
04/23/2013US8426424 Certain substituted amides, method of making, and method of use thereof
04/23/2013US8426420 Heterocyclic pyrazole-carboxamidesas P2Y12 antagonists
04/23/2013US8426409 7-tert-Butyl-3-(3-{8-[4-(morpholine-4-carbonyl)-phenylamino]-imidazo[1,2-a]pyrazin-6-yl}-phenyl)-3H-quinazolin-4-one; arthritis; inhibit Btk
04/23/2013US8426407 Preparation of 1-(substituted aryl)-5-trifluoromethyl-2-(1H)pyridone compounds and salts thereof and their applications
04/23/2013US8426405 Thiazopyrimidinones and uses thereof
04/23/2013US8426400 β-lactamyl phenylalanine, cysteine, and serine vasopressin antagonists
04/23/2013US8426389 Crystalline form of R)-3-(4-(2-(2-methyltetrazol-5-yl)pyridin-5-yl)-3-fluorophenyl)-5-hydroxymethyl oxazolidin-2-one dihydrogen phosphate
04/23/2013US8426145 Diagnostic method for celiac sprue
04/23/2013CA2697081C 5-(4-(haloalkoxy)phenyl)pyrimidine-2-amine compounds and compositions as kinase inhibitors
04/23/2013CA2634168C Quinolone based compounds exhibiting prolyl hydroxylase inhibitory activity, and compositions, and uses thereof
04/23/2013CA2555712C Novel cyclic compound having 4-pyridylalkylthio group having substituted or unsubstituted amino group introduced therein
04/23/2013CA2552419C Azadecalin glucocorticoid receptor modulators
04/23/2013CA2471355C Substituted diketopiperazines as oxytocin antagonists
04/18/2013WO2013056070A2 Heterocyclic compounds and methods of use thereof
04/18/2013WO2013056060A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
04/18/2013WO2013055793A1 Small molecules targeting androgen receptor nuclear localization and/or level in prostate cancer
04/18/2013WO2013054822A1 1 - arylcarbonyl - 4 - oxy - piperidine compounds useful for the treatment of neurodegenerative diseases
04/18/2013WO2013054291A1 Novel oxazine derivatives and their use in the treatment of disease
04/18/2013WO2013054146A1 New co crystals useful in the preparation of pharmaceutical compositions
04/18/2013WO2013053983A1 Protein kinase inhibitors
04/18/2013WO2013053872A1 Synthesis method and intermediates useful in the preparation of pyrrolobenzodiazepines
04/18/2013WO2013053739A1 Process for preparing factor xa inhibitors
04/18/2013WO2013053725A1 2-oxo-piperidinyl derivatives
04/18/2013WO2013053206A1 Quinazoline derivatives as kinases inhibitors and methods of use thereof
04/18/2013WO2013027196A9 Substituted 2-alkyl-1-oxo-n-phenyl-3-heteroaryl-1,2,3,4- tetrahydroisoquinoline-4-carboxamides for antimalarial therapies
04/18/2013US20130096301 Kinase inhibitors and method of treating cancer with same
04/18/2013US20130096300 Long wavelength fluorogenic intracellular ion indicators that are well retained in the cytosol
04/18/2013US20130096149 Heteroaryl compounds and compositions as protein kinase inhibitors
04/18/2013US20130096147 Raltegravir Salts and Crystalline Forms Thereof
04/18/2013US20130096139 Compounds Useful as Inhibitors of ATR Kinase
04/18/2013US20130096128 Pyrazole compounds useful as protein kinase inhibitors
04/18/2013US20130096124 5-aryl isoxazolines for controlling pests
04/18/2013US20130096122 Fused heterocyclic compounds as ion channel modulators
04/18/2013US20130096119 Isoquinolin-3-Ylurea Derivatives
04/18/2013US20130096117 Novel Compounds
04/18/2013US20130096115 Methods for treating autism
04/18/2013US20130096113 Heterocyclic compounds and methods of use thereof
04/18/2013US20130096108 Cyclic Inhibitors of 11Beta-Hydroxysteroid Dehydrogenase 1
04/18/2013US20130096102 Aminopyrimidine derivatives as lrrk2 modulators
04/18/2013US20130096101 Inhibitors of hcv ns5a
04/18/2013US20130096089 Heterocyclic Compounds for the Treatment of Neurological and Psychological Disorders
04/18/2013US20130096084 Novel heterocyclic compounds as erk inhbitors
04/18/2013US20130096083 Use of isoquinolones for preparing drugs, novel isoquinolones and method for synthesising same
04/18/2013US20130095193 Compounds useful as inhibitors of atr kinase
04/18/2013CA2851810A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors
04/18/2013CA2851445A1 Novel oxazine derivatives and their use in the treatment of disease
04/18/2013CA2851155A1 Heterocyclic compounds and methods of use thereof
04/18/2013CA2851087A1 1-arylcarbonyl-4-oxy-piperidine compounds useful for the treatment of neurodegenerative diseases
04/18/2013CA2850096A1 Synthesis method and intermediates useful in the preparation of pyrrolobenzodiazepines
04/18/2013CA2849385A1 2-oxo-piperidinyl derivatives
04/18/2013CA2848197A1 Protein kinase inhibitors
04/17/2013EP2581371A1 Pyrrolyl substituted dihydroindol-2-one derivatives, preparation methods and uses thereof
04/17/2013EP2581365A1 Heterocyclic compound, organic light-emitting diode comprising the heterocyclic compound, and flat panel display device comprising the organic light-emitting diode
04/17/2013EP2580211A1 Process for the preparation of dihydropyrrole derivatives
04/17/2013EP2580208A1 Cyclohexyl-azetidinyl antagonists of ccr2
04/17/2013EP2580207A1 Nitrogen containing heteroaryl compounds
04/17/2013EP2580200A1 5,6-dihydro-2h-[1,4]oxazin-3-yl-amine derivatives useful as inhibitors of beta-secretase (bace)
04/17/2013EP2579877A1 Morpholino pyrimidines and their use in therapy
04/17/2013EP2579873A1 Novel prolylcarboxypeptidase inhibitors
04/17/2013CN103052627A Pyrimidine derivatives as fak inhibitors
04/17/2013CN103044412A Azilsartan polymorph and preparation method thereof
04/17/2013CN103044411A Iloperidone drug cocrystal and preparation method thereof
04/17/2013CN103044409A Puerarin derivative or pharmaceutically acceptable salt and application thereof
04/17/2013CN103044350A Preparation of 1,3,4-oxadiazole compounds and application thereof in anticancer treatment drug
04/17/2013CN103044311A Multi-substituted indole compounds and preparation method and application thereof
04/17/2013CN102120740B Imidazoline compound chirally synthesized by using thiourea catalyst derived from rosin and application thereof in anti-inflammatory and antipyretic aspects
04/17/2013CN102030744B Iloperidone crystal and preparation method and medicinal composition thereof
04/17/2013CN101903380B 5-aminocyclylmethyl-oxazolidin-2-one derivatives
04/17/2013CN101679400B Novel carbamoyloxy aryl alkan arylpiperazine compound, pharmaceutical compositions comprising the compound and method for treating pain, anxiety and depression by administering the compound
04/17/2013CN101622248B N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as AXL inhibitors
04/17/2013CN101466670B Inhibitors of histone deacetylase
04/17/2013CN101171012B Stereoisomerically enriched 3-aminocarbonyl bicycloheptene pyrimidinediamine compounds and their uses
04/16/2013US8420820 Pyrrolopyridinylpyrimidin-2-ylamine derivatives
04/16/2013US8420676 Antibiotics with improved solubility, lower toxicity; potent antibacterial activity; includes Torezolid phosphate
04/16/2013US8420675 Aminotetrahydroindazoloacetic acids
04/16/2013US8420668 1-(2H)-isoquinolone derivative
04/16/2013US8420661 Arylethynyl derivatives
04/16/2013US8420641 Method of inhibiting CETP activity with 4-benzylamino-1-carboxylacyl-piperidine derivatives
04/16/2013US8420639 Arylsulfonamide CCR3 antagonists
04/16/2013US8420638 Triheterocyclic compounds and compositions thereof
04/16/2013US8420632 Benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
04/16/2013US8420630 Pyrimidine derivatives
04/16/2013US8420570 Chiral 3-(benzylsulfinyl)-5,5-dimethyl-4,5-dihydroisoxazole derivatives and 5,5-dimethyl-3-[(1H-pyrazol-4-ylmethyl)sulfinyl]-4,5-dihydroisoxazole derivatives, method for the production thereof, and use of same as herbicides and plant growth regulations
04/16/2013CA2737291C Nitrogen-containing heterocyclic compound and pest control agent
04/16/2013CA2712228C 4,5-dihydro-oxazol-2-yl amine derivatives
04/11/2013WO2013050454A1 Ethynyl derivatives as mglur5 allosteric modulators
04/11/2013WO2013050438A1 Substituted benzylindazoles for use as bub1 kinase inhibitors in the treatment of hyperproliferative diseases.
04/11/2013WO2013050421A1 Herbicidal pyridazinone derivatives
04/11/2013WO2013050302A1 Isoxazoline derivatives as insecticidal compounds
04/11/2013WO2013050270A1 Benzoxazine derivatives as crac modulators
04/11/2013WO2013024398A3 Improved method for quantitative determination of linezolid
04/11/2013WO2012170976A3 Compositions and methods for the production of pyrimidine and pyridine compounds with btk inhibitory activity
04/11/2013US20130090351 Analogues for the treatment or prevention of flavivirus infections
04/11/2013US20130090341 Heterocyclic compounds
04/11/2013US20130090338 New ccr2 receptor antagonists, method for producing the same, and use thereof as medicaments
04/11/2013US20130090337 Crystal of amide compound
04/11/2013US20130090333 Benzoxazine derivatives as crac modulators
04/11/2013US20130090332 Ethynyl derivatives
04/11/2013US20130090330 N3-heteroaryl substituted triazoles and n5-heteroaryl substituted triazoles useful as axl inhibitors
04/11/2013US20130090326 Antimicrobial Compounds and Methods of Making and Using the Same
1 ... 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 ... 647